{"id":"https://openalex.org/W2278665679","doi":"https://doi.org/10.18632/oncotarget.6353","title":"Taxanes enhance trastuzumab-mediated ADCC on tumor cells through NKG2D-mediated NK cell recognition","display_name":"Taxanes enhance trastuzumab-mediated ADCC on tumor cells through NKG2D-mediated NK cell recognition","alternate_titles":[],"publication_year":2015,"publication_date":"2015-11-21","ids":{"openalex":"https://openalex.org/W2278665679","doi":"https://doi.org/10.18632/oncotarget.6353","mag":"2278665679","pmid":"https://pubmed.ncbi.nlm.nih.gov/26595802","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4807996"},"language":"en","primary_location":{"id":"doi:10.18632/oncotarget.6353","doi":"https://doi.org/10.18632/oncotarget.6353","is_oa":true,"landing_page_url":"https://doi.org/10.18632/oncotarget.6353","pdf_url":"https://www.oncotarget.com/article/6353/pdf/","source":{"id":"https://openalex.org/S126644158","display_name":"Oncotarget","issn_l":"1949-2553","issn":["1949-2553"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","medline","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316297","host_organization_name":"Impact Journals LLC","host_organization_lineage":["https://openalex.org/P4310316297"],"host_organization_lineage_names":["Impact Journals LLC"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncotarget","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2278665679"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://www.oncotarget.com/article/6353/pdf/","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5072166447","display_name":"Martina Di Modica","orcid":"https://orcid.org/0000-0001-6320-5247","observed_orcids":["https://orcid.org/0000-0001-6320-5247"]},"institutions":[{"id":"https://openalex.org/I4210156707","display_name":"Fondazione IRCCS Istituto Nazionale dei Tumori","ror":"https://ror.org/05dwj7825","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4210156707"]}],"countries":["IT"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Martina Di Modica","raw_affiliation_strings":["Molecular Targeting Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Molecular Targeting Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy","institution_ids":["https://openalex.org/I4210156707"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017651486","display_name":"Lucia Sfondrini","orcid":"https://orcid.org/0000-0003-0350-5402","observed_orcids":["https://orcid.org/0000-0003-0350-5402"]},"institutions":[{"id":"https://openalex.org/I189158943","display_name":"University of Milan","ror":"https://ror.org/00wjc7c48","country_code":"IT","type":"education","lineage":["https://openalex.org/I189158943"]}],"countries":["IT"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Lucia Sfondrini","raw_affiliation_strings":["Dipartimento di Scienze Biomediche per la Salute, Universit\u00e0 degli Studi di Milano, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dipartimento di Scienze Biomediche per la Salute, Universit\u00e0 degli Studi di Milano, Milan, Italy","institution_ids":["https://openalex.org/I189158943"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049119014","display_name":"Viola Regondi","orcid":"https://orcid.org/0000-0002-0237-0860","observed_orcids":["https://orcid.org/0000-0002-0237-0860"]},"institutions":[{"id":"https://openalex.org/I4210156707","display_name":"Fondazione IRCCS Istituto Nazionale dei Tumori","ror":"https://ror.org/05dwj7825","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4210156707"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Viola Regondi","raw_affiliation_strings":["Molecular Targeting Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Molecular Targeting Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy","institution_ids":["https://openalex.org/I4210156707"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004666438","display_name":"Stefania Varchetta","orcid":"https://orcid.org/0000-0002-0289-2896","observed_orcids":["https://orcid.org/0000-0002-0289-2896"]},"institutions":[{"id":"https://openalex.org/I4210151645","display_name":"Policlinico San Matteo Fondazione","ror":"https://ror.org/05w1q1c88","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210151645","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Stefania Varchetta","raw_affiliation_strings":["Department of Infectious Diseases, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, Pavia, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Infectious Diseases, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, Pavia, Italy","institution_ids":["https://openalex.org/I4210151645"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028311121","display_name":"Barbara Oliviero","orcid":"https://orcid.org/0000-0002-0532-4608","observed_orcids":["https://orcid.org/0000-0002-0532-4608","https://orcid.org/0009-0006-6555-7581"]},"institutions":[{"id":"https://openalex.org/I4210151645","display_name":"Policlinico San Matteo Fondazione","ror":"https://ror.org/05w1q1c88","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210151645","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Barbara Oliviero","raw_affiliation_strings":["Department of Infectious Diseases, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, Pavia, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Infectious Diseases, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, Pavia, Italy","institution_ids":["https://openalex.org/I4210151645"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081344507","display_name":"Gabriella Mariani","orcid":"https://orcid.org/0000-0001-7733-3143","observed_orcids":["https://orcid.org/0000-0001-7733-3143"]},"institutions":[{"id":"https://openalex.org/I4210156707","display_name":"Fondazione IRCCS Istituto Nazionale dei Tumori","ror":"https://ror.org/05dwj7825","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4210156707"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Gabriella Mariani","raw_affiliation_strings":["Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy","institution_ids":["https://openalex.org/I4210156707"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020943144","display_name":"Giulia Bianchi","orcid":"https://orcid.org/0000-0003-3630-4527","observed_orcids":["https://orcid.org/0000-0003-3630-4527"]},"institutions":[{"id":"https://openalex.org/I4210156707","display_name":"Fondazione IRCCS Istituto Nazionale dei Tumori","ror":"https://ror.org/05dwj7825","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4210156707"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Giulia Valeria Bianchi","raw_affiliation_strings":["Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy","institution_ids":["https://openalex.org/I4210156707"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020078965","display_name":"Daniele Generali","orcid":"https://orcid.org/0000-0003-2480-3855","observed_orcids":["https://orcid.org/0000-0003-2480-3855"]},"institutions":[{"id":"https://openalex.org/I4210165579","display_name":"Istituti Ospitalieri di Cremona","ror":"https://ror.org/05w07vs91","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210165579"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Daniele Generali","raw_affiliation_strings":["Dipartimento di Terapia Molecolare e Farmacogenomica, Istituti Ospitalieri di Cremona, Cremona, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dipartimento di Terapia Molecolare e Farmacogenomica, Istituti Ospitalieri di Cremona, Cremona, Italy","institution_ids":["https://openalex.org/I4210165579"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079183289","display_name":"Andrea Balsari","orcid":"https://orcid.org/0000-0002-3250-2668","observed_orcids":["https://orcid.org/0000-0002-3250-2668"]},"institutions":[{"id":"https://openalex.org/I189158943","display_name":"University of Milan","ror":"https://ror.org/00wjc7c48","country_code":"IT","type":"education","lineage":["https://openalex.org/I189158943"]},{"id":"https://openalex.org/I4210156707","display_name":"Fondazione IRCCS Istituto Nazionale dei Tumori","ror":"https://ror.org/05dwj7825","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4210156707"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Andrea Balsari","raw_affiliation_strings":["Dipartimento di Scienze Biomediche per la Salute, Universit\u00e0 degli Studi di Milano, Milan, Italy","Molecular Targeting Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dipartimento di Scienze Biomediche per la Salute, Universit\u00e0 degli Studi di Milano, Milan, Italy","institution_ids":["https://openalex.org/I189158943"]},{"raw_affiliation_string":"Molecular Targeting Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy","institution_ids":["https://openalex.org/I4210156707"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077890463","display_name":"Tiziana Triulzi","orcid":"https://orcid.org/0000-0003-3050-8676","observed_orcids":["https://orcid.org/0000-0003-3050-8676"]},"institutions":[{"id":"https://openalex.org/I4210156707","display_name":"Fondazione IRCCS Istituto Nazionale dei Tumori","ror":"https://ror.org/05dwj7825","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4210156707"]}],"countries":["IT"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Tiziana Triulzi","raw_affiliation_strings":["Molecular Targeting Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Molecular Targeting Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy","institution_ids":["https://openalex.org/I4210156707"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5083469846","display_name":"Elda Tagliabue","orcid":"https://orcid.org/0000-0001-9877-2903","observed_orcids":["https://orcid.org/0000-0001-9877-2903"]},"institutions":[{"id":"https://openalex.org/I4210156707","display_name":"Fondazione IRCCS Istituto Nazionale dei Tumori","ror":"https://ror.org/05dwj7825","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4210156707"]}],"countries":["IT"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Elda Tagliabue","raw_affiliation_strings":["Molecular Targeting Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Molecular Targeting Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy","institution_ids":["https://openalex.org/I4210156707"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5017651486","https://openalex.org/A5072166447","https://openalex.org/A5077890463","https://openalex.org/A5083469846"],"corresponding_institution_ids":["https://openalex.org/I189158943","https://openalex.org/I4210156707"],"apc_list":null,"apc_paid":null,"fwci":1.3485,"has_fulltext":true,"cited_by_count":53,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.77703517,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":92,"max":99},"biblio":{"volume":"7","issue":"1","first_page":"255","last_page":"265"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11020","display_name":"Immune Cell Function and Interaction","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11020","display_name":"Immune Cell Function and Interaction","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.0013000000035390258,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/taxanes","display_name":"taxanes","score":0.7200000286102295},{"id":"https://openalex.org/keywords/docetaxel","display_name":"docetaxel","score":0.9490000009536743},{"id":"https://openalex.org/keywords/trastuzumab","display_name":"trastuzumab","score":0.9959999918937683},{"id":"https://openalex.org/keywords/antibody-dependent-cellular-cytotoxicity","display_name":"antibody-dependent cellular cytotoxicity","score":0.9490000009536743},{"id":"https://openalex.org/keywords/nkg2d","display_name":"NKG2D","score":0.8920000195503235},{"id":"https://openalex.org/keywords/natural-killer-cells","display_name":"natural killer cells","score":0.953000009059906},{"id":"https://openalex.org/keywords/her2-positive-breast-cancer","display_name":"HER2-positive breast cancer","score":0.9459999799728394},{"id":"https://openalex.org/keywords/neoadjuvant-therapy","display_name":"neoadjuvant therapy","score":0.6859999895095825},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.5149999856948853},{"id":"https://openalex.org/keywords/bt474-cells","display_name":"BT474 cells","score":0.7239999771118164},{"id":"https://openalex.org/keywords/mda-mb-361","display_name":"MDA-MB-361","score":0.9200000166893005},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.44999998807907104},{"id":"https://openalex.org/keywords/nk-cell-exhaustion","display_name":"NK cell exhaustion","score":0.4000000059604645}],"concepts":[{"id":"https://openalex.org/C40677261","wikidata":"https://www.wikidata.org/wiki/Q21418091","display_name":"Antibody-dependent cell-mediated cytotoxicity","level":4,"score":0.8037203550338745},{"id":"https://openalex.org/C2778867473","wikidata":"https://www.wikidata.org/wiki/Q17544382","display_name":"NKG2D","level":4,"score":0.7523709535598755},{"id":"https://openalex.org/C2779786085","wikidata":"https://www.wikidata.org/wiki/Q412616","display_name":"Trastuzumab","level":4,"score":0.6554895639419556},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5164730548858643},{"id":"https://openalex.org/C2781190966","wikidata":"https://www.wikidata.org/wiki/Q420436","display_name":"Docetaxel","level":3,"score":0.47973790764808655},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4714920222759247},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.4683949947357178},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.46265655755996704},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4197123050689697},{"id":"https://openalex.org/C2777511904","wikidata":"https://www.wikidata.org/wiki/Q425227","display_name":"Taxane","level":4,"score":0.41456156969070435},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3785710334777832},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3133013844490051},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.31188535690307617},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.27161890268325806},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2681484818458557},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.24566036462783813},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.20946604013442993},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.17977792024612427},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000068878","descriptor_name":"Trastuzumab","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000068878","descriptor_name":"Trastuzumab","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000077143","descriptor_name":"Docetaxel","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000920","descriptor_name":"Antibody-Dependent Cell Cytotoxicity","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D000920","descriptor_name":"Antibody-Dependent Cell Cytotoxicity","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D000920","descriptor_name":"Antibody-Dependent Cell Cytotoxicity","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D001952","descriptor_name":"Bridged-Ring Compounds","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D001952","descriptor_name":"Bridged-Ring Compounds","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D002478","descriptor_name":"Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004357","descriptor_name":"Drug Synergism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007694","descriptor_name":"Killer Cells, Natural","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D007694","descriptor_name":"Killer Cells, Natural","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D007694","descriptor_name":"Killer Cells, Natural","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015153","descriptor_name":"Blotting, Western","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015395","descriptor_name":"Histocompatibility Antigens Class I","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015972","descriptor_name":"Gene Expression Regulation, Neoplastic","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D016513","descriptor_name":"Mice, SCID","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019138","descriptor_name":"Antibodies, Blocking","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D019138","descriptor_name":"Antibodies, Blocking","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D020133","descriptor_name":"Reverse Transcriptase Polymerase Chain Reaction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D023041","descriptor_name":"Xenograft Model Antitumor Assays","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D036341","descriptor_name":"Intercellular Signaling Peptides and Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D043823","descriptor_name":"Taxoids","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D043823","descriptor_name":"Taxoids","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055655","descriptor_name":"NK Cell Lectin-Like Receptor Subfamily K","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D055655","descriptor_name":"NK Cell Lectin-Like Receptor Subfamily K","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D055655","descriptor_name":"NK Cell Lectin-Like Receptor Subfamily K","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D058851","descriptor_name":"GPI-Linked Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":6,"locations":[{"id":"doi:10.18632/oncotarget.6353","doi":"https://doi.org/10.18632/oncotarget.6353","is_oa":true,"landing_page_url":"https://doi.org/10.18632/oncotarget.6353","pdf_url":"https://www.oncotarget.com/article/6353/pdf/","source":{"id":"https://openalex.org/S126644158","display_name":"Oncotarget","issn_l":"1949-2553","issn":["1949-2553"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","medline","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316297","host_organization_name":"Impact Journals LLC","host_organization_lineage":["https://openalex.org/P4310316297"],"host_organization_lineage_names":["Impact Journals LLC"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncotarget","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:3803542","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4807996","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:4807996","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4807996/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncotarget","raw_type":"Text"},{"id":"pmid:26595802","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26595802","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncotarget","raw_type":"Journal Article"},{"id":"pmh:oai:arts.units.it:11368/2904488","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4807996","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4807996/pdf/oncotarget-07-0255.pdf","source":{"id":"https://openalex.org/S4306400480","display_name":"ArTS Archivio della ricerca di Trieste (University of Trieste https://www.units.it/)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I142444530","host_organization_name":"University of Trieste","host_organization_lineage":["https://openalex.org/I142444530"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:air.unimi.it:2434/342955","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/2434/342955","pdf_url":null,"source":{"id":"https://openalex.org/S4306400516","display_name":"Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I189158943","host_organization_name":"University of Milan","host_organization_lineage":["https://openalex.org/I189158943"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.18632/oncotarget.6353","doi":"https://doi.org/10.18632/oncotarget.6353","is_oa":true,"landing_page_url":"https://doi.org/10.18632/oncotarget.6353","pdf_url":"https://www.oncotarget.com/article/6353/pdf/","source":{"id":"https://openalex.org/S126644158","display_name":"Oncotarget","issn_l":"1949-2553","issn":["1949-2553"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","medline","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316297","host_organization_name":"Impact Journals LLC","host_organization_lineage":["https://openalex.org/P4310316297"],"host_organization_lineage_names":["Impact Journals LLC"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncotarget","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320323054","display_name":"Associazione Italiana per la Ricerca sul Cancro","ror":"https://ror.org/02g2x7380"},{"id":"https://openalex.org/F4320324448","display_name":"Fondazione Pezcoller","ror":"https://ror.org/051f3s362"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2278665679.pdf","grobid_xml":"https://content.openalex.org/works/W2278665679.grobid-xml"},"referenced_works_count":40,"referenced_works":["https://openalex.org/W111929474","https://openalex.org/W1589583253","https://openalex.org/W1969464492","https://openalex.org/W1977778943","https://openalex.org/W1982917143","https://openalex.org/W1990613023","https://openalex.org/W1992234802","https://openalex.org/W1994013015","https://openalex.org/W1994097025","https://openalex.org/W2011435623","https://openalex.org/W2015030901","https://openalex.org/W2027542837","https://openalex.org/W2038918212","https://openalex.org/W2046861708","https://openalex.org/W2051657147","https://openalex.org/W2051998002","https://openalex.org/W2066471812","https://openalex.org/W2086561544","https://openalex.org/W2087569038","https://openalex.org/W2089071484","https://openalex.org/W2095375388","https://openalex.org/W2098150432","https://openalex.org/W2100014422","https://openalex.org/W2100891604","https://openalex.org/W2104337757","https://openalex.org/W2107426197","https://openalex.org/W2108182027","https://openalex.org/W2112434826","https://openalex.org/W2114101532","https://openalex.org/W2125770488","https://openalex.org/W2128102844","https://openalex.org/W2130034035","https://openalex.org/W2138892734","https://openalex.org/W2142287133","https://openalex.org/W2143994426","https://openalex.org/W2146313292","https://openalex.org/W2147443000","https://openalex.org/W2148811436","https://openalex.org/W2152811375","https://openalex.org/W2560367415"],"related_works":["https://openalex.org/W2334193106","https://openalex.org/W1997920739","https://openalex.org/W2123228158","https://openalex.org/W1788305820","https://openalex.org/W6983799442","https://openalex.org/W3012490010","https://openalex.org/W1561552618","https://openalex.org/W2972614835","https://openalex.org/W1985429409","https://openalex.org/W2027542837"],"abstract_inverted_index":{"//":[0],"Martina":[1],"Di":[2],"Modica":[3],"1,":[4,39,44,49],"*":[5,10,45,50,130],",":[6,11,15,19,23,27,32,36,41,46,236],"Lucia":[7],"Sfondrini":[8],"2,":[9],"Viola":[12],"Regondi":[13],"1":[14,51],"Stefania":[16],"Varchetta":[17],"3":[18,22,85],"Barbara":[20],"Oliviero":[21],"Gabriella":[24],"Mariani":[25],"4":[26,31,104],"Giulia":[28],"Valeria":[29],"Bianchi":[30],"Daniele":[33],"Generali":[34],"5":[35,117],"Andrea":[37],"Balsari":[38],"2":[40,70],"Tiziana":[42],"Triulzi":[43],"Elda":[47,141],"Tagliabue":[48],"Molecular":[52,60],"Targeting":[53],"Unit,":[54],"Department":[55,86,105],"of":[56,87,106,202,226,281,305,320],"Experimental":[57],"Oncology":[58],"and":[59,176,191,210,219,233,266,361,364],"Medicine,":[61],"Fondazione":[62,90,109],"IRCCS":[63,110],"Istituto":[64,91,111],"Nazionale":[65,112],"dei":[66,113],"Tumori,":[67,114],"Milan,":[68,83,115],"Italy":[69,84,103,116,129],"Dipartimento":[71,118],"di":[72,81,92,119,126],"Scienze":[73],"Biomediche":[74],"per":[75],"la":[76],"Salute,":[77],"Universit\u00e0":[78],"degli":[79],"Studi":[80],"Milano,":[82],"Infectious":[88],"Diseases,":[89],"Ricovero":[93],"e":[94,122],"Cura":[95],"a":[96,170,239],"Carattere":[97],"Scientifico":[98],"Policlinico":[99],"San":[100],"Matteo,":[101],"Pavia,":[102],"Medical":[107],"Oncology,":[108],"Terapia":[120],"Molecolare":[121],"Farmacogenomica,":[123],"Istituti":[124],"Ospitalieri":[125],"Cremona,":[127,128],"These":[131],"authors":[132],"have":[133],"contributed":[134],"equally":[135],"to":[136,205,279,355],"this":[137,196,254],"work":[138],"Correspondence":[139],"to:":[140],"Tagliabue,":[142],"e-mail:":[143],"elda.tagliabue@istitutotumori.mi.it":[144],"Keywords:":[145],"breast":[146,182],"cancer,":[147],"docetaxel,":[148],"ADCC,":[149],"NK":[150,207,227,268,290,325,362],"cell,":[151],"NKG2D":[152,250,256,306,321,344],"Received:":[153],"October":[154],"28,":[155],"2015":[156,160,164],"Accepted:":[157],"November":[158,162],"09,":[159],"Published:":[161],"21,":[163],"ABSTRACT":[165],"Recent":[166],"clinical":[167],"data":[168],"indicate":[169,349],"synergistic":[171],"therapeutic":[172],"effect":[173],"between":[174],"trastuzumab":[175,371],"taxanes":[177,351,367],"in":[178,231,234,242,243,264,331,378],"neoadjuvantly":[179],"treated":[180,221],"HER2-positive":[181],"cancer":[183],"(BC)":[184],"patients.":[185],"In":[186],"HER2+":[187,214,294],"BC":[188,215,295],"experimental":[189],"models":[190],"patients,":[192],"we":[193],"investigated":[194],"whether":[195],"synergy":[197],"depends":[198],"on":[199,322,359],"the":[200,249,282,318,374],"ability":[201],"drug-induced":[203],"stress":[204],"improve":[206],"cell":[208,216,287],"effectiveness":[209],"thus":[211],"trastuzumab-mediated":[212,245,329],"ADCC.":[213],"lines":[217],"BT474":[218],"MDAMB361":[220],"with":[222,273,299,342,370,380],"docetaxel":[223,262],"showed":[224],"up-modulation":[225],"activator":[228],"ligands":[229],"both":[230],"vitro":[232,244,332],"vivo":[235],"accompanied":[237],"by":[238,261,357],"15\u201340%":[240],"increase":[241,277,352],"ADCC;":[246],"antibodies":[247],"blocking":[248],"receptor":[251,257,307],"significantly":[252],"reduced":[253],"enhancement.":[255],"expression":[258],"was":[259],"increased":[260],"treatment":[263,298],"circulating":[265],"splenic":[267],"cells":[269,291],"from":[270,293,314,340],"mice":[271],"xenografted":[272],"tumor":[274,353,360],"cells,":[275,326,363],"an":[276],"related":[278],"expansion":[280],"CD11b":[283],"+":[284,286],"Ly6G":[285],"population.":[288],"Accordingly,":[289],"derived":[292],"patients":[296,316,341,379],"after":[297],"taxane-containing":[300],"therapy":[301],"expressed":[302],"higher":[303],"levels":[304],"than":[308],"before":[309],"treatment.":[310],"Moreover,":[311],"plasma":[312,339],"obtained":[313],"these":[315],"recapitulated":[317],"modulation":[319],"healthy":[323],"donors\u2019":[324],"improving":[327],"their":[328],"activity":[330],".":[333],"This":[334],"enhancement":[335],"occurred":[336],"mainly":[337],"using":[338],"low":[343,381],"basal":[345,382],"expression.":[346],"Our":[347],"results":[348],"that":[350,366],"susceptibility":[354],"ADCC":[356],"acting":[358],"suggest":[365],"concomitantly":[368],"administered":[369],"could":[372],"maximize":[373],"antibody":[375],"effect,":[376],"especially":[377],"immune":[383],"effector":[384],"cytotoxic":[385],"activity.":[386]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2278665679","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":7},{"year":2022,"cited_by_count":11},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":6},{"year":2017,"cited_by_count":5}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
